Syndromic testing

Get the latest insights with syndromic testing webinars

Syndromic testing with the QIAstat-Dx system allows you to rapidly and simultaneously survey a large number of pathogens in a single sample. This means you can get comprehensive diagnostic answers in around an hour. And patients can get the right treatment faster.

To learn more about the benefits of QIAstat-Dx syndromic testing and hear about the latest insights on molecular diagnostics for infectious disease, watch our most recent webinars.

Bring the accuracy of syndromic testing to your lab
Make the right choice for your lab – contact us today.
Go beyond fast results
Go beyond fast results
Learn how multiplex PCR testing offers a variety of benefits for healthcare institutions, including improved patient management and cost savings.
Explore benefits
Syndromic testing simplified
Syndromic testing simplified
Set your lab up for success with a streamlined syndromic test. The QIAstat-Dx panels redefine ease-of-use with less than one minute hands-on time and a seamless sample to result workflow.
Discover QIAstat-Dx
Get in touch
Get in touch
Contact the QIAGEN team to learn more about QIAstat-Dx syndromic testing or to place an order.
Contact us

The QIAstat-Dx Analyzer is intended for in vitro diagnostic use.

The QIAstat-Dx Respiratory SARS-CoV-2 Panel is intended for in vitro diagnostic use.

  • This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories;
  • This product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and
  • This emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetics Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declarations is terminated or authorization is revoked sooner.
  • Products and product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.